Family Office Of America (FOFA) Research & Development (2021 - 2023)
Family Office Of America (FOFA) posted Research & Development of $1500.0 for Q1 2023, down 93.51% sequentially from $23100.0 in Q4 2022, and down 87.67% YoY from $12167.0 in Q1 2022.
Family Office Of America (FOFA) Research & Development (2021 - 2023) Analysis & Trends
Family Office Of America has reported Research & Development for 3 years, with the latest figure at $1500.0 in Q1 2023.
- Quarterly Research & Development fell 87.67% year-over-year to $1500.0 in Q1 2023, while the trailing twelve-month figure through Dec 2023 was $1500.0 (down 98.14% YoY) and the FY2023 annual result came in at $1500.0, down 98.04% from the prior year.
- Research & Development declined to $1500.0 in Q1 2023 per FOFA's latest filing, from $23100.0 in the prior quarter.
- Over five years, Research & Development peaked at $128479.0 in Q2 2021 and troughed at $1500.0 in Q1 2023.
- A 3-year average of $65333.1 and a median of $45418.0 in 2022 frame the typical range for Research & Development.
- The sharpest annual moves came in 2022 and 2023: Research & Development tumbled 64.65% in 2022, then tumbled 87.67% in 2023.
- Over 3 years, Research & Development stood at $124734.0 in 2021, then sank by 81.48% to $23100.0 in 2022, then slumped by 93.51% to $1500.0 in 2023.
- According to Business Quant data, Research & Development over the past three periods registered $1500.0, $23100.0, and $45418.0 for Q1 2023, Q4 2022, and Q2 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 129.71 Bn | 126.23 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 120.07 Bn | 110.85 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 34.03 Bn | 31.92 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.51 Bn | 23.19 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Family Office Of America | 27.84 Mn | 27.20 Mn | 532,674.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 1,500.00 |
| Dec 31, 2022 | 23,100.00 |
| Jun 30, 2022 | 45,418.00 |
| Mar 31, 2022 | 12,167.00 |
| Dec 31, 2021 | 124,734.00 |
| Sep 30, 2021 | 121,934.00 |
| Jun 30, 2021 | 128,479.00 |